Sumary of A major ivermectin study has been withdrawn, so what now for the controversial drug?:
- Ivermectin, an existing drug against parasites including head lice, has had a chequered history when it comes to treating COVID-19. The bulk of studies so far show there’s not enough evidence ivermectin is useful in treating or preventing COVID-19, either alone or with antibiotics or supplements.
- Now a large clinical trial that seemed to show positive results for ivermectin has been withdrawn.
- Here’s what the evidence says so far and what we can expect next.
- Ivermectin was identified as a potential COVID-19 treatment based on experiments in isolated cells and animals.
- As the pandemic progressed, so did ivermectin clinical trials.
- But when experts who write doctors’ prescribing guidelines reviewed the data, they found not enough evidence to back ivermectin to treat or prevent COVID-19. These groups included Australia’s National COVID-19 Clinical Evidence Taskforce and the World Health Organization.
- Instead, they said ivermectin should only be used in clinical trials.
- Ivermectin is still not a miracle cure for COVID-19, despite what you may have read The most robust summary of the evidence for ivermectin in COVID-19, published in June, goes one step further.